Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17636398

Download in:

View as

General Info

PMID
17636398